Induction of pregnant women onto opioid-agonist maintenance medication: An analysis of withdrawal symptoms and study retention

被引:14
作者
Holbrook, Amber M. [1 ]
Jones, Hendree E. [2 ,3 ,4 ]
Heil, Sarah H. [5 ,6 ]
Martin, Peter R. [7 ,8 ]
Stine, Susan M. [9 ]
Fischer, Gabriele [10 ]
Coyle, Mara G. [11 ]
Kaltenbach, Karol [1 ,12 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pediat, Philadelphia, PA 19107 USA
[2] RTI Int, Res Triangle Pk, NC 27709 USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21224 USA
[4] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21224 USA
[5] Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA
[6] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA
[7] Vanderbilt Univ, Dept Psychiat, Nashville, TN 37212 USA
[8] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37212 USA
[9] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA
[10] Med Univ Vienna, Ctr Publ Hlth, Dept Psychiat & Psychotherapy, A-1090 Vienna, Austria
[11] Brown Univ, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02905 USA
[12] Thomas Jefferson Univ, Dept Psychiat & Human Behav, Jefferson Med Coll, Philadelphia, PA 19107 USA
关键词
Pregnancy; Opioid dependence; Buprenorphine induction; CINA; Opioid withdrawal; Methodone induction; NEONATAL ABSTINENCE SYNDROME; METHADONE-MAINTENANCE; BUPRENORPHINE; DEPENDENCE; OUTCOMES; TRIAL;
D O I
10.1016/j.drugalcdep.2013.02.031
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Induction onto buprenorphine during pregnancy may be more challenging than induction onto methadone. This study explores factors predicting withdrawal intensities and compares trajectories of withdrawal during the induction phase between opioid-dependent women randomly assigned to methadone or buprenorphine. Methods: A secondary analysis was conducted on data from 175 opioid-dependent pregnant women inducted onto buprenorphine or methadone subsequent to stabilization on morphine sulfate. ANOVA analyses were conducted to determine differences between mean peak CINA scores by medication and completion status. General linear mixed models were fitted to compare trajectories of CINA scores between methadone and buprenorphine conditions, and between study dropouts and completers within the buprenorphine condition. Results: Both buprenorphine and methadone patients experienced withdrawal categorized as minimal by the CINA scoring system. Significant differences in mean peak CINA scores for the first 72 hours of induction were found between the methadone (4.5; SD = 0.4) and buprenorphine conditions (6.9; SD = 0.4), with buprenorphine patients exhibiting higher mean peak CINA scores [F (3, 165) = 9.70, p<0.001]. The trajectory of CINA scores showed buprenorphine patients exhibiting a sharper increase in mean CINA scores than methadone patients [F (1, 233) = 8.70, p = 0.004]. There were no differences in mean peak CINA scores [F (3, 77) = 0.08, p = 0.52] or in trajectory of CINA scores [F (1, 166) = 0.42, p = 0.52] between buprenorphine study dropouts and completers. Conclusion: While mean peak CINA score was significantly higher in the buprenorphine condition than the methadone condition, neither medication condition experienced substantial withdrawal symptoms. Further research on factors related to successful induction to buprenorphine treatment in pregnant women is needed. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:329 / 334
页数:6
相关论文
共 27 条
[1]   French field experience with buprenorphine [J].
Auriacombe, M ;
Fatséas, M ;
Dubernet, J ;
Daulouède, JP ;
Tignol, J .
AMERICAN JOURNAL ON ADDICTIONS, 2004, 13 :S17-S28
[2]  
Center for Substance Abuse Treatment, 2004, TREATM IMPR PROT TIP, V04-3939
[3]   Heroin detoxification with buprenorphine on an inpatient psychiatric unit [J].
DiPaula, BA ;
Schwartz, R ;
Montoya, ID ;
Barrett, D ;
Tang, C .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2002, 23 (03) :163-169
[4]   Pregnancy outcome in women who use opiates [J].
Fajemirokun-Odudeyi, O. ;
Sinha, C. ;
Tutty, S. ;
Pairaudeau, P. ;
Armstrong, D. ;
Phillips, T. ;
Lindow, S. W. .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 126 (02) :170-175
[5]   Treatment of opioid-dependent pregnant women with buprenorphine [J].
Fischer, G ;
Johnson, RE ;
Eder, H ;
Jagsch, R ;
Peternell, A ;
Weninger, M ;
Langer, M ;
Aschauer, HN .
ADDICTION, 2000, 95 (02) :239-244
[6]   Buprenorphine versus methadone maintenance for the treatment of opioid dependence [J].
Fischer, G ;
Gombas, W ;
Eder, H ;
Jagsch, R ;
Peternell, A ;
Stühlinger, G ;
Pezawas, L ;
Aschauer, HN ;
Kasper, S .
ADDICTION, 1999, 94 (09) :1337-1347
[7]   Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates [J].
Gaalema, Diann E. ;
Scott, Teresa Linares ;
Heil, Sarah H. ;
Coyle, Mara G. ;
Kaltenbach, Karol ;
Badger, Gary J. ;
Arria, Amelia M. ;
Stine, Susan M. ;
Martin, Peter R. ;
Jones, Hendree E. .
ADDICTION, 2012, 107 :53-62
[8]   (R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy [J].
Gordon, Andrea L. ;
Lopatko, Olga V. ;
Somogyi, Andrew A. ;
Foster, David J. R. ;
White, Jason M. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (06) :895-902
[9]   Buprenorphine for the management of opioid withdrawal [J].
Gowing, L. ;
Ali, R. ;
White, J. M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03)
[10]  
JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P501